GenoME Diagnostics
GenoME Diagnostics develops a platform to expedite biomarker discovery and diagnostic development using DNA methylation and fragmentomic analysis. The company's lead products, OvaME and PanME, are blood tests designed for the early detection and monitoring of ovarian and pancreatic cancers. These liquid biopsy tools target the healthcare market to improve recurrence detection and patient outcomes.
Visit websiteBelfast, Ireland
Healthtech
Biotechnology
Diagnostics
Oncology
Funding summary
- Total raised
- €1.6M
- Funding rounds
- 1
Investors in GenoME Diagnostics
Investors on record for GenoME Diagnostics. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like GenoME Diagnostics?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors